Zota Health Care Limited will attend a virtual investor conference organized by Nirmal Bang Securities on June 15, 2026. The meeting, scheduled under Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, will feature one-on-one and group interactions with analysts and institutional investors. The company confirmed that no unpublished price sensitive information will be shared during the session.

The disclosure was made to The National Stock Exchange of India Limited. Ashvin Variya, Group Company Secretary & Compliance Officer, signed the intimation on behalf of the company.

The details of the scheduled meeting are as follows:

Presentations used during the meeting will be drawn from business update materials already available in the public domain on the company's and stock exchange websites.

[Zota Health Care Limited](zota healthcare) has released the transcript of its earnings conference call for the fourth quarter and financial year ended March 31, 2026. The company reported a robust financial performance for the year, driven by the expansion of its Davaindia retail network and improved operational leverage. Consolidated revenue from operations for FY26 stood at INR 53,865 lakhs, registering a year-on-year growth of 83.86%. The Davaindia business emerged as the primary growth engine, with sales growing more than double to INR 41,741 lakhs.

Financial Performance Highlights

The company achieved a significant turnaround at the operating level in FY26, reporting positive EBITDA of INR 2,597 lakhs compared to a negative EBITDA in the previous year. The EBITDA margin improved to 4.82% for the full year. On a quarterly basis, Q4FY26 EBITDA stood at INR 1,191 lakhs with a margin of 7.3%. Gross profit increased to INR 32,468 lakhs, a growth of over 108% year-on-year, while the gross margin expanded by 714 basis points to 60.28%.

Operational Expansion

During FY26, the company added 997 new Davaindia stores, comprising 804 Company-Owned Company-Operated (COCO) stores and 193 Franchisee-Owned Franchisee-Operated (FOFO) stores. This expansion took the total network to 2,579 stores nationwide. The company reported strong same-store growth (SSG), with stores operational as of March 2025 delivering overall SSG of over 40%. Stores aged 24 months and above recorded SSG of 35% to 40%, while those aged 12 to 24 months achieved SSG of 55% to 60%.

Strategic Initiatives and Outlook

Zota Health Care completed a Qualified Institutional Placement (QIP) of INR 350 crores to strengthen its balance sheet. The company increased its stake in Everyday Herbal Beauty Care Limited to 87.78% to reinforce backward integration. Looking ahead, the management plans to open 500 to 700 stores in FY27, with a focus on improving store-level profitability and operational efficiency. The company remains confident in its long-term vision of scaling to over 5,000 Davaindia stores by FY29.

The disclosure was submitted to The National Stock Exchange of India Limited in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ashvin Variya, Company Secretary & Compliance Officer, signed the disclosure.